Aggregated News From Investment Management Regulators

Publication of financial reports: Federal Office of Justice imposes disciplinary fine against Elanix Biotechnologies AG

Report/Flag

Please complete the required fields.



On 13 March 2020, the Federal Office of Justice (Bundesamt für JustizBfJ) imposed a disciplinary fine amounting to 2,500 euros against Elanix Biotechnologies AG.

The disciplinary fine order related to a breach of section 325 of the German Commercial Code (HandelsgesetzbuchHGB) by Elanix Biotechnologies AG. Elanix Biotechnologies AG had failed to submit its accounting documents for the financial year 2018 for the purpose of disclosure to the operator of the German Federal Gazette (Bundesanzeiger) in electronic form within the prescribed period. The legal basis for the sanction is section 335 of the HGB.

The company can lodge a complaint against the disciplinary fine order.

Regulator Information

Recent Articles

Commission Statement on the Passing of Former Chairman Harvey Pitt

We mourn the passing of Harvey Pitt, the 26th Chairman of the Securities and Exchange Commission.

Adjudication Order in respect of Fort Gloster Industries Limited in the matter of Illiquid Stock Options at BSE.

This news item was originally published by the Securities and Exchange Board of India (SEBI IN). See the article here: Read more

Career Spotlight – Benjamin Ellul, Junior Analyst, Office of the Chief Officer Supervision

Benjamin Ellul – Junior Analyst, Office of the Chief Officer Supervision, MFSA Benjamin joined the MFSA in March of 2022 as an intern.

Adjudication Order in respect of Fendra Infrastructure Pvt Ltd. in the matter of Illiquid Stock Options at BSE.

This news item was originally published by the Securities and Exchange Board of India (SEBI IN). See the article here: Read more

Get the latest from Regulatory.News in your inbox!

×